Review of antiviral peptides for use against zoonotic and selected non-zoonotic viruses
Viruses remain one of the leading causes of animal and human disease. Some animal viral infections spread sporadically to human populations, posing a serious health risk. Particularly the emerging viral zoonotic diseases such as the novel, zoonotic coronavirus represent an actual challenge for the s...
| Main Authors: | , , , |
|---|---|
| Format: | info:ar-repo/semantics/artículo |
| Language: | Inglés |
| Published: |
Elsevier
2022
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/20.500.12123/12019 https://www.sciencedirect.com/science/article/pii/S0196978121000784 https://doi.org/10.1016/j.peptides.2021.170570 |
Similar Items: Review of antiviral peptides for use against zoonotic and selected non-zoonotic viruses
- Bovine interferon lambda Is a potent antiviral against SARS-CoV-2 infection in vitro
- An inhibitory mechanism of action of coiled‐coil peptides against type three secretion system from enteropathogenic Escherichia coli
- P26 enhances baculovirus gene delivery by modulating the mammalian antiviral response
- Artificial microRNAs as antiviral strategy to FMDV: structural implications of target selection
- Antiviral efficacy of short-hairpin RNAs and artificial microRNAs targeting foot and-mouth disease virus
- Zoonotic RVA: State of the Art and Distribution in the Animal World